CD8A and glioma: IL-12 was the dominant cytokine that was markedly upregulated and has been implicated as an essential regulator of cytotoxic CD8+ T cells, CAR-T cells34, and NK cell subsets35 in solid tumor models including melanoma31 and glioma36 with recently demonstrated clinical potential for glioma treatment37.